FreshRecalls

Ascend Laboratories recalls

3 recent recalls on record for Ascend Laboratories in CPSC, NHTSA, and FDA data as of July 24, 2026 at 1:09 AM UTC.

Models with recalls

Amlodipine and Olmesartan Medoxomil Tablets (1)Ascend Laboratories (1)Minocycline Hydrochloride Extended-Release Tablets (1)

All Ascend Laboratories recalls

FDA Class II · Drug · June 17, 2026

Minocycline Hydrochloride Extended-Release Tablets recall — Ascend Laboratories, LLC

Failed Dissolution Specifications: An out-of-specification (OOS) result was observed during the 9th month of dissolution test analysis

Official ID D-0597-2026 · Official record ↗

FDA Class II · Drug · June 10, 2026

Amlodipine and Olmesartan Medoxomil Tablets recall — Ascend Laboratories, LLC

Failed Dissolution Specifications: Olmesartan Medoxomil content below specifications

Official ID D-0556-2026 · Official record ↗

FDA Class II · Drug · May 20, 2026

Ascend Laboratories recall — Ascend Laboratories, LLC

Failed Dissolution Specifications

Official ID D-0547-2026 · Official record ↗

Verify with the official sources:

Found something wrong or missing? Report a data error.

Compiled from official public-domain government data. Last checked July 24, 2026 at 1:09 AM UTC.